"
Team:ITESM-Guadalajara/Property
From 2014.igem.org
(Difference between revisions)
| (14 intermediate revisions not shown) | |||
| Line 221: | Line 221: | ||
.faceBot{ | .faceBot{ | ||
| - | background: | + | background: #202020; |
} | } | ||
| Line 249: | Line 249: | ||
border-bottom: 1px solid #AAA; | border-bottom: 1px solid #AAA; | ||
margin-bottom: 30px; | margin-bottom: 30px; | ||
| + | } | ||
| + | |||
| + | li.menu-item{ | ||
| + | background: transparent !important; | ||
} | } | ||
| Line 314: | Line 318: | ||
padding-left: 50px; | padding-left: 50px; | ||
} | } | ||
| - | + | .invertir:hover { | |
| + | -webkit-filter: invert(100%); | ||
| + | } | ||
</style> | </style> | ||
| Line 329: | Line 335: | ||
<div class="row"> | <div class="row"> | ||
<div class="col-md-2"></div> | <div class="col-md-2"></div> | ||
| - | + | <div class="col-md-3"><a href="https://2014.igem.org/Team:ITESM-Guadalajara"><img class="inicioLogo" src="https://static.igem.org/mediawiki/2014/5/55/BioPhrameIgem_logo.png" height="100" width="auto" ></a></div> | |
<div class="col-md-1"></div> | <div class="col-md-1"></div> | ||
<div class="col-md-6" > | <div class="col-md-6" > | ||
| Line 362: | Line 368: | ||
<span class="green-effect"></span> | <span class="green-effect"></span> | ||
</a> | </a> | ||
| - | </li> | + | </li><li class="menu-item"> |
| + | <a href="https://2014.igem.org/Team:ITESM-Guadalajara/Notebook"> | ||
| + | <span>Notebook</span> | ||
| + | <span class="green-effect"></span> | ||
| + | </a> | ||
| + | </li><li> | ||
| + | <a href="http://www.facebook.com/biophrame"> | ||
| + | <img src="https://static.igem.org/mediawiki/2014/3/30/BIOPHRAMEGDLFacebookF.png" height="20" width="auto" class="invertir img-rounded"> | ||
| + | </a></li> | ||
</ul> | </ul> | ||
</div> | </div> | ||
| Line 369: | Line 383: | ||
<div class="main-content"> | <div class="main-content"> | ||
<div class="col-md-2 col-md-offset-2 left_menu"> | <div class="col-md-2 col-md-offset-2 left_menu"> | ||
| - | <ul class="nav nav-pills nav-stacked"> | + | <ul class="nav nav-pills nav-stacked text-right"> |
<li class="left_menu_item"><a href="https://2014.igem.org/Team:ITESM-Guadalajara/Company">The Company</a></li> | <li class="left_menu_item"><a href="https://2014.igem.org/Team:ITESM-Guadalajara/Company">The Company</a></li> | ||
<li class="left_menu_item"><a href="https://2014.igem.org/Team:ITESM-Guadalajara/Product">Our Product</a></li> | <li class="left_menu_item"><a href="https://2014.igem.org/Team:ITESM-Guadalajara/Product">Our Product</a></li> | ||
| Line 386: | Line 400: | ||
<h2>INTELLECTUAL PROPERTY</h2> | <h2>INTELLECTUAL PROPERTY</h2> | ||
| - | <p> | + | </br><p align="justify"> |
Given the high-end technology and innovation Biophrame is creating, IP protection is needed. | Given the high-end technology and innovation Biophrame is creating, IP protection is needed. | ||
</p> | </p> | ||
<hr/> | <hr/> | ||
<h4>Patent protection and trade secrets</h4> | <h4>Patent protection and trade secrets</h4> | ||
| - | <p>The technology that we developed consists in: | + | <p align="justify">The technology that we developed consists in: |
| - | </p><p> | + | </p><p align="justify"> |
| - | The design of a genetically modified E. coli, that in our process is the responsible of the chitin deacetylation process. | + | <ul><li>The design of a genetically modified <i>E. coli</i>, that in our process is the responsible of the chitin deacetylation process. |
| - | We are currently patenting our first invention: the design of the genetically modified E. coli able to deacetylate chitin to produce Chitosan. We started the technology research at the IMPI (Mexican Institute for Intellectual Property), on September 17 (official documents available upon request), and we will start the patent process on January of 2015 in order to apply to government funds. The patent will be registered under the name of | + | </li></ul> |
| - | </p><p> | + | </p><p align="justify"> |
| + | We are currently patenting our first invention: the design of the genetically modified <i>E. coli</i> able to deacetylate chitin to produce Chitosan. We started the technology research at the IMPI (Mexican Institute for Intellectual Property), on September 17 (official documents available upon request), and we will start the patent process on January of 2015 in order to apply to government funds. The patent will be registered under the name of Biophrame Technologies as moral person (once it is legally established). | ||
| + | </p><p align="justify"> | ||
On the other hand, we will keep our innovative chitosan purification process as a trade secret, but we plan to establish a patent for this invention in other step of our Company development. | On the other hand, we will keep our innovative chitosan purification process as a trade secret, but we plan to establish a patent for this invention in other step of our Company development. | ||
</p> | </p> | ||
<hr/> | <hr/> | ||
| + | </div> | ||
| + | <div class="col-md-12 faceBot"></br><div class="col-md-2 col-md-offset-3"><img src="https://static.igem.org/mediawiki/2014/e/ef/Biophrame_logo_footer_500x150.png" class="img-responsive"><small style="color:white">Biophrame Technologies is a biotech company and manufacturer specialized in the production of Chitosan.</small></div> | ||
| + | <div class="col-md-2"> | ||
| + | <iframe src="//www.facebook.com/plugins/likebox.php?href=https%3A%2F%2Fwww.facebook.com%2Fbiophrame&width&height=258&colorscheme=dark&show_faces=true&header=false&stream=false&show_border=false" scrolling="no" frameborder="0" style="border:none; overflow:hidden; height:258px;" allowTransparency="true"></iframe></div> | ||
</div> | </div> | ||
</body> | </body> | ||
</html> | </html> | ||
Latest revision as of 18:56, 10 January 2015
